Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges

The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has attracted rapidly evolving attention as a cancer treatment modality because of its competence to selectively eliminate tumor cells without instigating toxicity in vivo. TRAIL has revealed encouraging promise in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Razeghian, Ehsan, Suksatan, Wanich, Sulaiman Rahman, Heshu, Bokov, Dmitry O., Abdelbasset, Walid Kamal, Hassanzadeh, Ali, Marofi, Faroogh, Yazdanifar, Mahboubeh, Jarahian, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417882/
https://www.ncbi.nlm.nih.gov/pubmed/34489946
http://dx.doi.org/10.3389/fimmu.2021.699746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417882/
https://www.ncbi.nlm.nih.gov/pubmed/34489946
http://dx.doi.org/10.3389/fimmu.2021.699746

Ejemplares similares